Study suggests non-coding RNA, long considered genomic dark matter, has potential in anti-inflammation Scientists develop synthetic long noncoding RNAs as potential anti-inflammatory drugs, with University of Toronto's Omar Khan showing promising results in human cells and mice.

Study suggests long non-coding RNA (lncRNA) has potential as new class of genetic medicine, including as an anti-inflammatory drug. I talked to the scientists at University of Toronto to learn more for my story in @endpts.com: endpoints.news/study-sugges...

Re-engineering long noncoding RNA (lncRNA) from the human transcriptome as exogenous drugs capable of treating disease.

Exciting news! We created the first therapeutics from the dark transcriptome & are featured as the cover article in Science Signaling! We chemically synthesized & optimized #lncRNA from the dark transcriptome & used them as exogenous drugs to treat disease. #medsky #scisky #science lnkd.in/dpNEaJ8j